Related Experiment Video
Updated: Sep 29, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation
Eva V Varga1, Marc Rubenzik, Vanessa Grife
1Department of Pharmacology and the Sarver Heart Center, College of Medicine, The University of Arizona Health Sciences Center, Tucson 85724, USA.
Abstract:
Chronic delta-opioid receptor agonist treatment of Chinese hamster ovary (CHO) cells stably expressing the human delta-opioid receptor (hDOR/CHO) leads to increased cAMP formation after the removal of the agonist (adenylyl cyclase superactivation). We have previously found that at the same time, chronic delta-opioid receptor agonist treatment augments phosphorylation of the adenylyl cyclase VI isoenzyme. Since phosphorylation of adenylyl cyclase VI by Raf-1 protein kinase was recently shown, we tested the role of Raf-1 in adenylyl cyclase superactivation in hDOR/CHO cells. We found that pretreatment of the cells with the selective Raf-1 inhibitor GW5074 (3-(3,5-dibromo-4-hydroxybenzylidene-5-iodo-1,3-dihydro-indol-2-one) (10 microM, 30 min) attenuates chronic deltorphin II-mediated increase in forskolin-stimulated cAMP formation by 40% (n = 6, P < 0.05). Better understanding of the molecular mechanism of adenylyl cyclase superactivation should aid in the development of analgesics that act longer and have fewer side effects.
More Related Videos
06:03Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ
Published on: March 22, 2024
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
MAPK Signaling Cascades
Opioid Receptors: Overview
GPCR Desensitization
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Cascades